Indication
Immune Thrombocytopenia
The Immune Thrombocytopenia pipeline: 2 tracked drugs, 1 approved for this indication.
Coverage in progress.The assets here come from their companies' published pipelines. AssetMemo has not yet run its full census of every drug in development for Immune Thrombocytopenia, so this list is not complete.
1 approved / phase 41 Phase 1/2
Compare the share prices of listed companies in Immune Thrombocytopenia →
Market size not yet sourced. How markets are sized ↗